The Food and Drug Administration says Kim Kardashian’s social media posts promoting Diclegis, an prescription anti-morning sickness drug, violate federal drug promotion rules because they don’t mention potentially dangerous side effects and drug interactions.
The Food and Drug Administration says Kim Kardashian’s social media posts promoting Diclegis, an prescription anti-morning sickness drug, violate federal drug promotion rules because they don’t mention potentially dangerous side effects and drug interactions. LIONEL CIRONNEAU Associated Press
The Food and Drug Administration says Kim Kardashian’s social media posts promoting Diclegis, an prescription anti-morning sickness drug, violate federal drug promotion rules because they don’t mention potentially dangerous side effects and drug interactions. LIONEL CIRONNEAU Associated Press

Opinion Columns & Blogs

Kavita Shah Arora: Why federal regulators care about Kim Kardashian’s Instagram feed

August 17, 2015 9:05 AM

  Comments  

Videos